Navigation Links
Genetic study shows direct link between vitamin D and MS susceptibility 'gene'
Date:2/5/2009

/p>

"In people with the DRB1 variant associated with MS, it seems that vitamin D may play a critical role," says co-author Dr Julian Knight. "If too little of the vitamin is available, the gene may not function properly."

"We have known for a long time that genes and environment determine MS risk," says Professor George Ebers, University of Oxford. "Here we show that the main environmental risk candidate vitamin D and the main gene region are directly linked and interact."

Professor Ebers and colleagues believe that vitamin D deficiency in mothers or even in a previous generation may lead to altered expression of DRB1*1501 in offspring.

The finding that the environment interacts directly with the background genetics of MS complements research recently published in Human Molecular Genetics by Professor Ebers's group. There, they showed that environment changes to the same gene region can increase the risk of developing MS even further and can be inherited. These so-called "epigenetic effects" are being seen as increasingly important by scientists and there may be ways in which the effects reported in these two papers are related.

"Epigenetics will have important implications, not only for MS, but for other common diseases," says Professor Ebers. "For mothers, taking care of their health during their reproductive years may have beneficial effects on the health of their future children or even grandchildren."

The authors hypothesise that this gene-environment interaction may affect the ability of the thymus, a key component of the immune system, to perform its regular tasks. The thymus produces an army of T cells, which identify invading pathogens, such as bacteria and viruses, and attack and destroy them. There are millions of different T cells, each designed to recognise a specific pathogen, but there is a risk that one type might mistakenly identify one of the body's own cells or proteins.
'/>"/>

Contact: Catriona Silvey
press@plos.org
Public Library of Science
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Does the desire to consume alcohol and tobacco come from our genetic makeup?
2. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
3. Many parents at-risk for cancer disclose genetic test results to children
4. Genetics determine optimal drug dose of common anticoagulant
5. Claims of sex-related differences in genetic association studies often not properly validated
6. American College of Medical Genetics responds to new FDA labeling decision for warfarin
7. UNC study questions FDA genetic-screening guidelines for cancer drug
8. Genome study shines light on genetic link to height
9. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
10. Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring
11. Rutgers Genetics receives $7.8 million for autism research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)... 2009 Agios Pharmaceuticals today announced that ...e, that the mutated IDH1 gene has a novel enzyme a...oncogene. This breakthrough discovery shows that t...ydroxyglutarate (2HG), which may contribute to the...he most common type of brain cancers. This discove...
(Date:11/20/2009)...k on many scientific and technological frontiers. ...ded support that totals nearly $4.3 million for th...nder the American Recovery and Reinvestment Act of...ants for investigation of solar phenomena. Philip ... enhance the capabilities of NJIT,s Big Bear Solar...
(Date:11/20/2009)...ents of plasma lipoprotein concentrations determin...), researchers led by Daniel Chasman at Brigham an...oston, MA, the Framingham Heart Study in Framingha...en and Oxford, England performed genetic associati...omen of European ancestry from the Women,s Genome ...
Breaking Biology News(10 mins):Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2ARmark Authentication Technologies LLC and Colorcon Inc Announce Alliance 6078 1ARmark Authentication Technologies LLC and Colorcon Inc Announce Alliance 6078 2ARmark Authentication Technologies LLC and Colorcon Inc Announce Alliance 6078 3Connection between depression and osteoporosis detailed by Hebrew University researchers 60956 1Connection between depression and osteoporosis detailed by Hebrew University researchers 60956 2Retirement Brings Most a Big Health Boost 60954 1Retirement Brings Most a Big Health Boost 60954 2Retirement Brings Most a Big Health Boost 60954 3
... YORK, MARCH 19 Ten prominent journalists from th...ve been selected for the fifth annual TempletonCam...n. Inaugurated in 2004, the fellowships include a...sity of Cambridge in England. The 2009 fellows we...empletonCambridge Fellowships, which are funded by...
...Nov. 1, 1933, Mrs. Bruce Reid recorded seeing both...s. And on May 28, 1938, Oscar McKinley Bryans obse...ng that the birds were most common when apple tree... 6 million personal observations scribbled and pre... record more than a century of information about b...
...s Hopkins engineers have invented a method that co...eak free from neighboring tissue, an "escape" that.... The new lab-on-a-chip, described in the March is... better cancer therapies. , "Studying cell detach...standing the way cancer cells metastasize," says p...
Other Biology News:Fifth annual Templeton-Cambridge fellowships awarded to 10 noted journalists 2Fifth annual Templeton-Cambridge fellowships awarded to 10 noted journalists 3Fifth annual Templeton-Cambridge fellowships awarded to 10 noted journalists 4It's for the birds 2It's for the birds 3Lab-on-a-chip homes in on how cancer cells break free 2Lab-on-a-chip homes in on how cancer cells break free 3
(Date:11/20/2009)...Nov. 20 Novavax, Inc. (N...an underwritten public offering of 6,800,000 share...$3.30 per share. The approximately $21 million of...scounts and commissions, will be used for preclini...accines, internal research and development program...
(Date:11/20/2009)...TLER TOLEDO recently announced that Dr. Dominique ...ole of Process Analytical Technology (PAT) in Gree...er 1, 2009. , (PRWEB) Nov...Analytical Technology (PAT) in Green Chemistry and... Analytical Technology (PAT) case studies will be ...
(Date:11/19/2009)...v. 19 Dr. Mate Hidvegi, inventor o... a press release issued on November 17 by Birophar...ing false and self-serving statements about its U....vegi stated from his office in Budapest, Hungary: ...ar does not apply to AveULTRA, www.aveultra.com ...
(Date:11/19/2009)...nd WALTHAM, Mass., Nov. 19 Arlingt...find that the leading driver of antibiotic selecti...trum activity against gram-positive and gram-negat...t can cause nosocomial pneumonia, surveyed Europea...gents that provide appropriate coverage against co...
Breaking Biology Technology:Novavax Prices Public Offering of Common Stock 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
...ers at MIT and Texas Instruments have unveiled a n...e up to 10 times more energy-efficient than presen..., implantable medical devices and sensors that las...nnovative design will be presented Feb. 5 at the I...n Francisco by Joyce Kwong, a graduate student in ...
...e Cross and Blue Shield of,Texas (BCBSTX) is annou...,a new integrated medical-dental program. The prog...an individual,s medical and dental data to,create ...his new approach,is designed to specifically help ...er decisions about their oral health through the p...
...Scientific,Corporation (NYSE: BSX ) today announc...ll year ended December 31, 2007, as well as guidan...the first quarter of 2008., Fourth quarter highl...ord net sales of $2.152 billion, both exceedin...hythm management (CRM) sales 11 percent -- Achiev...
Other Biology Technology:Team develops energy-efficient microchip 2Blue Cross and Blue Shield of Texas Launches an Integrated Medical-Dental Health Program 2Blue Cross and Blue Shield of Texas Launches an Integrated Medical-Dental Health Program 3Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 2Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 3Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 4Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 5Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 6Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 7Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 8Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 9Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 10Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 11Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 12Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 13Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 14Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 15Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 16Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 17Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 18Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 19Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 20Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 21Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 22Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 23Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 24Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 25Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 26Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 27Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 28Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 29
Rabbit Anti-Human IFN-Alpha / Beta R2 (IFNAR2) (CD118) Neutralizing Polyclonal Antibody, Unconjugated from PBL InterferonSource
ImageQuant 400 from GE Healthcare, formerly Amersham Biosciences
ImageQuant 100 UV from GE Healthcare, formerly Amersham Biosciences
IMAGEQUANT 300 IQTL from GE Healthcare, formerly Amersham Biosciences
Biology Products: